Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
Add more filters










Publication year range
1.
Technol Health Care ; 32(S1): 197-206, 2024.
Article in English | MEDLINE | ID: mdl-38759049

ABSTRACT

BACKGROUND: The speech reception threshold (SRT), synonymous with the speech recognition threshold, denotes the minimum hearing level required for an individual to discern 50% of presented speech material. This threshold is measured independently in each ear with a repetitive up-down adjustment of stimulus level starting from the initial SRT value derived from pure tone thresholds (PTTs), measured via pure-tone audiometry (PTA). However, repetitive adjustments in the test contributes to increased fatigue for both patients and audiologists, compromising the reliability of the hearing tests. OBJECTIVE: Determining the first (initial) sound level closer to the finally determined SRT value, is important to reduce the number of repetitions. The existing method to determine the initial sound level is to average the PTTs called pure tone average (PTAv). METHODS: We propose a novel method using a machine learning approach to estimate a more optimal initial sound level for the SRT test. Specifically, a convolutional neural network with 1-dimensional filters (1D CNN) was implemented to predict a superior initial level than the conventional methods. RESULTS: Our approach produced a reduction of 37.92% in the difference between the initial stimulus level and the final SRT value. CONCLUSIONS: This outcome substantiates that our approach can reduce the repetitions for finding the final SRT, and, as the result, the hearing test time can be reduced.


Subject(s)
Audiometry, Pure-Tone , Speech Reception Threshold Test , Humans , Speech Reception Threshold Test/methods , Audiometry, Pure-Tone/methods , Adult , Male , Female , Machine Learning , Reproducibility of Results , Auditory Threshold/physiology , Neural Networks, Computer , Speech Perception/physiology
2.
Acta Biomater ; 116: 356-367, 2020 10 15.
Article in English | MEDLINE | ID: mdl-32927089

ABSTRACT

The development of nanoparticles that can be used as stimuli-responsive drug carriers for the treatment of different diseases has been an emerging area of research. In this study, we designed a chitosan-bilirubin micelle (ChiBil) carrying losartan, which is responsive to intrinsic reactive oxygen species (ROS), for the treatment of hepatic fibrosis. Because bilirubin is hydrophobic in nature, its carboxyl group was conjugated to an amine group from chitosan using EDC-NHS chemistry to form an amphiphilic conjugate, ChiBil. Losartan is an angiotensin receptor blocker that reduces hepatic fibrosis, and it was used as the therapeutic payload in this study to form ChiBil-losartan micelles. The release characteristics of ChiBil-losartan were tested by ROS generation to confirm losartan release. Human hepatic stellate cell line LX2 was found to be the best in vitro model for the study. The reduction of hepatic stellate cell activation after treatment with ChiBil-losartan was analyzed based on the expression of alpha-smooth muscle actin (α-SMA) in both in vitro and in vivo studies. Advanced liver fibrosis was induced in C3H/HeN mice using a thioacetamide (TAA) via intraperitoneal injection and 10% ethanol (EtOH) in their drinking water. In addition, the hydroxyproline levels, histopathological evaluation, and mRNA quantification in the liver showed a decreased collagen content in the treated groups compared to that in the untreated control group. Macrophage infiltration studies and qPCR studies of inflammatory markers also proved the reduction of hepatic fibrosis in the treatment group. The intravenous administration of ChiBil-losartan resulted in decreased fibrosis in a TAA/EtOH-induced liver fibrosis mouse model. The in vitro and in vivo results suggest that the ROS stimuli-responsive ChiBil nanoparticles carrying losartan may be a potent therapeutic option for the treatment of hepatic fibrosis. The combined effect of losartan and bilirubin exhibited a decreased hepatic fibrosis both in vitro and in vivo.


Subject(s)
Chitosan , Animals , Bilirubin , Fibrosis , Liver/pathology , Liver Cirrhosis/drug therapy , Liver Cirrhosis/pathology , Mice , Mice, Inbred C3H , Reactive Oxygen Species , Theranostic Nanomedicine
3.
PLoS One ; 15(5): e0232619, 2020.
Article in English | MEDLINE | ID: mdl-32428024

ABSTRACT

Chronic liver diseases such as hepatitis B viral (HBV) infection and liver fibrosis have been a major health problem worldwide. However, less research has been conducted owing to the lack of animal models. The key purpose of this study was to determine the effects of different hepatotoxins in HBV-affected liver. In this study, we successfully generated a combined liver fibrosis model by administering HBV 1.2 plasmid and thioacetamide/ethanol (TAA/EtOH). To our knowledge, this is the first study in which an increase in the liver fibrosis level is observed by the intraperitoneal administration of TAA and EtOH in drinking water after the hydrodynamic transfection of the HBV 1.2 plasmid in C3H/HeN mice. The HBV+TAA/EtOH group exhibited higher level of hepatic fibrosis than that of the control groups. The hepatic stellate cell activation in the TAA- and EtOH-administered groups was demonstrated by the elevation in the level of fibrotic markers. In addition, high levels of collagen content and histopathological results were also used to confirm the prominent fibrotic levels. We established a novel HBV mice model by hydrodynamic injection-based HBV transfection in C3H/HeN mice. C3H/HeN mice were reported to have a higher HBV persistence level than that of the C57BL/6 mouse model. All the results showed an increased fibrosis level in the HBV mice treated with TAA and EtOH; hence, this model would be useful to understand the effect of hepatotoxins on the high risk of fibrosis after HBV infection. The acceleration of liver fibrosis can occur with prolonged administration as well as the high dosage of hepatotoxins in mice.


Subject(s)
Ethanol/toxicity , Hepatitis B virus , Hepatitis B/complications , Liver Cirrhosis, Experimental/chemically induced , Liver Cirrhosis, Experimental/virology , Liver/drug effects , Liver/virology , Thioacetamide/toxicity , Animals , Female , Hep G2 Cells , Humans , Liver/pathology , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Plasmids
4.
Int J Mol Sci ; 19(12)2018 Dec 04.
Article in English | MEDLINE | ID: mdl-30518139

ABSTRACT

Currently, immunotherapy is considered to be one of the effective treatment modalities for cancer. All the developments and discoveries in this field up to the recent Nobel Prize add to the interest for research into this vast area of study. Targeting tumor environment as well as the immune system is a suitable strategy to be applied for cancer treatment. Usage of nanoparticle systems for delivery of immunotherapeutic agents to the body being widely studied and found to be a promising area of research to be considered and investigated further. Nanoparticles for immunotherapy would be one of the effective treatment options for cancer therapy in the future due to their high specificity, efficacy, ability to diagnose, imaging, and therapeutic effect. Among the many nanoparticle systems, polylactic-co-glycolic acid (PLGA) nanoparticles, liposomes, micelles, gold nanoparticles, iron oxide, dendrimers, and artificial exosomes are widely used for immunotherapy of cancer. Moreover, the combination therapy found to be the more effective way of treating the tumor. Here, we review the current trends in nanoparticle therapy and efficiency of these nanosystems in delivering antigens, adjuvants, therapeutic drugs, and other immunotherapeutic agents. This review summarizes the currently available bioactive nanoparticle systems for cancer immunotherapy.


Subject(s)
Biocompatible Materials/chemistry , Immunotherapy , Metal Nanoparticles/chemistry , Neoplasms/immunology , Neoplasms/therapy , Animals , Gold/chemistry , Humans , Immunity
5.
BMC Cancer ; 15: 217, 2015 Apr 02.
Article in English | MEDLINE | ID: mdl-25881148

ABSTRACT

BACKGROUND: The proliferating activity of a single leukemia stem cell and the molecular mechanisms for their quiescent property remain unknown, and also their prognostic value remains a matter of debate. Therefore, this study aimed to demonstrate the quiescence property and molecular signature of leukemia stem cell and their clinicopathological implications. METHODS: Single cell sorting and culture were performed in the various sets of hematopoietic stem cells including CD34+CD38- acute myeloid leukemia (AML) cell population (ASCs) from a total of 60 patients with AML, and 11 healthy controls. Their quiescence related-molecular signatures and clinicopathological parameters were evaluated in AML patients. RESULTS: Single cell plating efficiency of ASCs was significantly lower (8.6%) than those of normal hematopoietic stem cells i.e.: cord blood, 79.0%; peripheral blood, 45.3%; and bone marrow stem cell, 31.1%. Members of the TGFß super-family signaling pathway were most significantly decreased; as well as members of the Wnt, Notch, pluripotency maintenance and hedgehog pathways, compared with non ASC populations. mtDNA copy number of ASCs was significantly lower than that of corresponding other cell populations. However, our data couldn't support the prognostic value of the ASCs in AML. CONCLUSIONS: ASCs showed remarkable lower plating efficiency and slower dividing properties at the single cell level. This quiescence is represented as a marked decrease in the mtDNA copy number and also linked with down-regulation of genes in various molecular pathways.


Subject(s)
ADP-ribosyl Cyclase 1/metabolism , Antigens, CD34/metabolism , Leukemia/genetics , Leukemia/metabolism , Neoplastic Stem Cells/metabolism , Resting Phase, Cell Cycle/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Cell Culture Techniques , DNA, Mitochondrial , Female , Flow Cytometry , Gene Dosage , Gene Expression Profiling , Gene Expression Regulation, Leukemic , Humans , Leukemia/mortality , Leukemia/pathology , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/metabolism , Leukemia, Myeloid, Acute/mortality , Leukemia, Myeloid, Acute/pathology , Male , Middle Aged , Prognosis , Tumor Stem Cell Assay , Young Adult
6.
Mol Cancer ; 9: 124, 2010 May 27.
Article in English | MEDLINE | ID: mdl-20504375

ABSTRACT

BACKGROUND: Androgen signaling plays a critical role in the development of prostate cancer and its progression. However, androgen-independent prostate cancer cells emerge after hormone ablation therapy, resulting in significant clinical problems. We have previously demonstrated that the HOXB13 homeodomain protein functions as a prostate cancer cell growth suppressor by inhibiting androgen-mediated signals. However, the role of the HOXB13 in androgen-independent growth of prostate cancer cells remains unexplained. RESULTS: In this report, we first demonstrated that HOXB13 was highly overexpressed in hormone-refractory tumors compared to tumors without prostate-specific antigen after initial treatment. Functionally, in an androgen-free environment minimal induction of HOXB13 in LNCaP prostate cancer cells, to the level of the normal prostate, markedly promoted cell proliferation while suppression inhibited cell proliferation. The HOXB13-mediated cell growth promotion in the absence of androgen, appears to be mainly accomplished through the activation of RB-E2F signaling by inhibiting the expression of the p21waf tumor suppressor. Indeed, forced expression of HOXB13 dramatically decreased expression of p21waf; this inhibition largely affected HOXB13-mediated promotion of E2F signaling. CONCLUSIONS: Taken together, the results of this study demonstrated the presence of a novel pathway that helps understand androgen-independent survival of prostate cancer cells. These findings suggest that upregulation of HOXB13 is associated with an additive growth advantage of prostate cancer cells in the absence of or low androgen concentrations, by the regulation of p21-mediated E2F signaling.


Subject(s)
E2F Transcription Factors/metabolism , Homeodomain Proteins/metabolism , Prostatic Neoplasms/metabolism , Signal Transduction/physiology , Aged , Aged, 80 and over , Antibody Specificity , Blotting, Western , Cell Line, Tumor , Cyclin-Dependent Kinase Inhibitor p21/genetics , Cyclin-Dependent Kinase Inhibitor p21/metabolism , E2F Transcription Factors/genetics , Homeodomain Proteins/genetics , Humans , Immunohistochemistry , Male , Middle Aged , Prostatic Neoplasms/genetics , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Transfection
7.
BMC Cancer ; 10: 197, 2010 May 13.
Article in English | MEDLINE | ID: mdl-20462455

ABSTRACT

BACKGROUND: Coactivator-associated arginine methyltransferase 1 (CARM1) functions as a transcriptional coactivator of androgen receptor (AR)-mediated signaling. Correspondingly, overexpression of CARM1 has been associated with the development of prostate cancer (PCa) and its progression to androgen-independent PCa. In our preliminary study, however, the promoting effects of CARM1, with regard to androgen-stimulated AR target gene expression were minimal. These results suggested that the AR target gene expression associated with CARM1 may result primarily from non-hormone dependent activity. The goal of this study was to confirm the pattern of expression of CARM1 in human tumors and determine the mechanism of action in CARM1 overexpressed tumors. METHODS: Tissue microarray was used to determine the pattern of expression of CARM1 in human cancers by immunohistochemistry. CARM1 expression was also evaluated in prostate and colorectal surgical specimens and the clinical records of all cases were reviewed. In addition, a reporter transcription assay using the prostate-specific antigen (PSA) promoter was used to identify the signaling pathways involved in non-hormone-mediated signal activation associated with CARM1. RESULTS: The tissue microarray showed that CARM1 was particularly overexpressed in the colorectal cancers while CARM1 expression was not prevalent in the prostate and breast cancers. Further studies using surgical specimens demonstrated that CARM1 was highly overexpressed in 75% of colorectal cancers (49 out of 65) but not in the androgen-independent PCa. In addition, CARM1's coactivating effect on the entire PSA promoter was very limited in both androgen-dependent and androgen-independent PCa cells. These results suggest that there are other factors associated with CARM1 expression in PSA regulation. Indeed, CARM1 significantly regulated both p53 and NF-kappaB target gene transcription. CONCLUSIONS: The results of this study suggest that, in addition to its role in activation of steroid receptors, CARM1 functions as a transcriptional modulator by altering the activity of many transcriptional factors, especially with regard to androgen independent PCa and colorectal cancers.


Subject(s)
Biomarkers, Tumor/metabolism , Colorectal Neoplasms/enzymology , Prostatic Neoplasms/enzymology , Protein-Arginine N-Methyltransferases/metabolism , Androgens/metabolism , Animals , Biomarkers, Tumor/genetics , Breast Neoplasms/enzymology , Cell Line, Tumor , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Female , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Male , Mutation , NF-kappa B/genetics , NF-kappa B/metabolism , Neoplasm Staging , Promoter Regions, Genetic , Prostate-Specific Antigen/genetics , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Protein-Arginine N-Methyltransferases/genetics , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Tissue Array Analysis , Transcription, Genetic , Transfection , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Up-Regulation
8.
Anat Cell Biol ; 43(4): 284-93, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21267402

ABSTRACT

During the prostate cancer (PCa) development and its progression into hormone independency, androgen receptor (AR) signals play a central role by triggering the regulation of target genes, including prostate-specific antigen. However, the regulation of these AR-mediated target genes is not fully understood. We have previously demonstrated a unique role of HOXB13 homeodomain protein as an AR repressor. Expression of HOXB13 was highly restricted to the prostate and its suppression dramatically increased hormone-activated AR transactivation, suggesting that prostate-specific HOXB13 was a highly potent transcriptional regulator. In this report, we demonstrated the action mechanism of HOXB13 as an AR repressor. HOXB13 suppressed androgen-stimulated AR activity by interacting with AR. HOXB13 did neither bind to AR responsive elements nor disturb nuclear translocation of AR in response to androgen. In PCa specimen, we also observed mutual expression pattern of HOXB13 and AR. These results suggest that HOXB13 not only serve as a DNA-bound transcription factor but play an important role as an AR-interacting repressor to modulate hormone-activated androgen receptor signals. Further extensive studies will uncover a novel mechanism for regulating AR-signaling pathway to lead to expose new role of HOXB13 as a non-DNA-binding transcriptional repressor.

9.
FEMS Microbiol Lett ; 269(1): 170-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17263846

ABSTRACT

Bacterial swarming constitutes a good in vitro model for surface adherence and colonization, and is accompanied by expressions of virulence factors related to invasiveness. In this study, it was determined that Vibrio vulnificus swarming was abolished by mutation of the vvpE gene encoding a metalloprotease VvpE and this swarming defect was recovered by complementation of the vvpE gene. Expression of the vvpE gene began simultaneously with the beginning of swarming and increased along with expression of the luxS gene encoding the synthase of the precursor of quorum-sensing signal molecule autoinducer 2, and this increased vvpE expression was decreased by mutation of the luxS gene. Moreover, VvpE destroyed IgA and lactoferrins, which are responsible for mucosal immunity. These results suggest that VvpE may play important roles in the surface adherence and colonization of V. vulnificus by facilitating swarming and in the mucosal invasion of V. vulnificus by destroying IgA and lactoferrin.


Subject(s)
Bacterial Proteins/physiology , Metalloproteases/physiology , Vibrio vulnificus/enzymology , Vibrio vulnificus/pathogenicity , Bacterial Adhesion/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Carbon-Sulfur Lyases/genetics , Carbon-Sulfur Lyases/metabolism , Gene Expression Regulation, Bacterial , Genetic Complementation Test , Humans , Immunoglobulin A/metabolism , Lactoferrin/metabolism , Metalloproteases/genetics , Mutation , Quorum Sensing , Vibrio vulnificus/physiology
10.
J Infect Dis ; 195(1): 90-8, 2007 Jan 01.
Article in English | MEDLINE | ID: mdl-17152012

ABSTRACT

We determined the ferrophilic characteristics of Vibrio vulnificus to evaluate the potential usefulness of iron chelation therapy for the prevention of V. vulnificus infection. Readily available non-transferrin-bound iron (NTBI) is required for the initiation of V. vulnificus growth under in vitro iron-limited conditions and human ex vivo conditions. NTBI aided efficient transferrin-bound iron (TBI) use by V. vulnificus, and the vulnibactin-mediated iron-uptake system was expressed after bacterial growth had been started by NTBI. V. vulnificus required higher NTBI levels for the initiation of growth, produced siderophores at lower levels, and used TBI less efficiently than other bacteria. In addition, the growth of V. vulnificus was inhibited by deferiprone, a clinically available iron chelator. These results show that V. vulnificus is a ferrophilic bacterium that requires higher NTBI levels than other pathogens and that iron chelation therapy might be an effective means of preventing the in vivo growth of V. vulnificus in susceptible patients.


Subject(s)
Ferric Compounds/metabolism , Iron/metabolism , Transferrin/metabolism , Vibrio vulnificus/metabolism , Bacterial Proteins , Iron Chelating Agents/therapeutic use , Repressor Proteins , Vibrio vulnificus/enzymology , Vibrio vulnificus/growth & development
11.
Biol Pharm Bull ; 29(11): 2295-300, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17077532

ABSTRACT

In order to determine whether Pseudomonas aeruginosa alkaline protease AprA is involved in facilitating siderophore-mediated iron-acquisition from human transferrins, we measured bacterial growth, the production of siderophore and AprA, iron-acquisition from transferrins, and the proteolytic cleavage of transferrins in an alkaline minimal medium (pH 8.3) containing human transferrins as an iron source and compared these on a time scale. The growth of P. aeruginosa was found to be stimulated in proportion to the iron-saturation levels of transferrins. AprA production and the proteolytic cleavage of transferrins began concomitantly with siderophore production from the early growth phase when P. aeruginosa was actively growing and consuming most iron for growth. However, the AprA-free, but siderophore-containing, culture ultrafiltrates could also remove iron from transferrin. These results indicate that alkaline protease AprA can facilitate the siderophore-mediated iron-uptake of P. aeruginosa via the proteolytic cleavage of transferrins. However, the proteolytic cleavage by AprA is not essentially required for iron-acquisition from transferrins.


Subject(s)
Bacterial Proteins/metabolism , Endopeptidases/metabolism , Iron/pharmacokinetics , Pseudomonas aeruginosa/enzymology , Siderophores/biosynthesis , Transferrin/metabolism , Anemia, Iron-Deficiency/metabolism , Bacterial Proteins/genetics , Biological Transport , Cell Division , Culture Media, Conditioned/analysis , Culture Media, Conditioned/chemistry , Endopeptidases/genetics , Humans , Hydrogen-Ion Concentration , Iron/metabolism , Peptide Hydrolases/genetics , Peptide Hydrolases/metabolism , Pseudomonas Infections/metabolism , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/metabolism , RNA, Bacterial/genetics , RNA, Bacterial/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Time Factors
12.
FEMS Immunol Med Microbiol ; 47(2): 226-32, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16831209

ABSTRACT

To elucidate the mechanisms underlying the in vivo suppression and inactivation of Vibrio vulnificus hemolysin (VvhA), we used cirrhotic ascites fluid as a human ex vivo experimental system. VvhA expression was suppressed in proportion to the amount of cirrhotic ascites. The expression of vvhA in undiluted cirrhotic ascites could be suppressed further by the addition of glucose, a constituent of cirrhotic ascites. VvhA was readily inactivated in the presence of cirrhotic ascites by a cholesterol-mediated oligomerization and interaction with an undefined constituent(s) of cirrhotic ascites. These results indicate that the expression of vvhA can be suppressed and that any VvhA produced is inactivated by the constituents of cirrhotic ascites. Our results suggest that only a very small portion of the VvhA that is produced in human body fluids may actually contribute to the pathogenesis of V. vulnificus septicemia. It is suggested that cirrhotic ascites could be used as a human ex vivo experimental system for the studies on the in vivo expression and the significance of V. vulnificus virulence factors.


Subject(s)
Bacterial Proteins/antagonists & inhibitors , Bacterial Proteins/biosynthesis , Liver Cirrhosis/immunology , Liver Cirrhosis/microbiology , Vibrio vulnificus/metabolism , Ascites/immunology , Ascites/microbiology , Bacterial Proteins/genetics , Cholesterol/pharmacology , Glucose/pharmacology , Hemolysin Proteins , Humans , Liver Cirrhosis/metabolism , Liver Cirrhosis/pathology , Vibrio vulnificus/genetics
13.
J Microbiol ; 44(2): 226-32, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16728960

ABSTRACT

Swarming has proven to be a good in vitro model for bacterial surface adherence and colonization, and the swarming differentiation of a bacterium has been shown to be coupled with changes in the expression of virulence factors associated with its invasiveness, particularly in the early stages of infection. In this study, we attempted to determine whether the expression of vvhA, which encodes for hemolysin/cytolysin (VvhA), is either upregulated or downregulated during the swarming differentiation of V. vulnificus. The insertional inactivation of vvhA itself exerted no detectable effect on the expression of V. vulnificus swarming motility. However, in our lacZ-fused vvhA transcriptional reporter assay, vvhA expression decreased in swarming V. vulnificus as compared to non-swarming or planktonic V. vulnificus. The reduced expression of vvhA in swarming V. vulnificus increased as a result of the deletional inactivation of luxS, a gene associated with quorum sensing. These results show that vvhA expression in swarming V. vulnificus is downregulated via the activity of the LuxS quorum-sensing system, suggesting that VvhA performs no essential role in the invasiveness of V. vulnificus via the adherence to and colonization on the body surfaces required in the early stages of the infection. However, VvhA may play a significant role in the pathophysiological deterioration occurring after swarming V. vulnificus is differentiated into planktonic V. vulnificus.


Subject(s)
Bacterial Proteins/physiology , Cell Movement/genetics , Gene Expression Regulation, Bacterial , Vibrio vulnificus/pathogenicity , Bacterial Adhesion/genetics , Bacterial Proteins/genetics , Carbon-Sulfur Lyases , Cell Differentiation , Down-Regulation , Genes, Reporter/genetics , Mutation , Up-Regulation , Vibrio vulnificus/cytology , Vibrio vulnificus/genetics
14.
Biol Pharm Bull ; 29(5): 911-8, 2006 May.
Article in English | MEDLINE | ID: mdl-16651718

ABSTRACT

The roles of metalloprotease (VvpE) and catechol-siderophore (vulnibactin) in the uptake of iron from human transferrins by Vibrio vulnificus have been determined using different experimental conditions and methods. Therefore, in this study, we attempted to elucidate the roles of VvpE and vulnibactin using the same methods and experimental conditions, in an in vitro and a human ex vivo system, and in accordance with the molecular version of Koch's postulates. Neither vvpE mutation nor in trans vvpE complementation affected vulnibactin production, iron-assimilation from human holotransferrin (HT), and bacterial growth in a HT-containing deferrated Heart-Infusion medium (HT-DF-HI) or a HT-containing cirrhotic ascites (HT-CA). In contrast, the mutation of fur gene encoding Fur, a repressor regulating expression of the vulnibactin-mediated iron-uptake system, derepressed vulnibactin production, and facilitated iron-assimilation from HT and bacterial growth in HT-DF-HI or HT-CA. The mutation of vis gene encoding isochorismate synthase required for vulnibactin synthesis abolished vulnibactin production, iron-assimilation from HT and bacterial growth in HT-DF-HI or HT-CA. These results demonstrate that vulnibactin is essentially required for iron-assimilation from transferrin, and that VvpE has no direct effect on facilitating vulnibactin-mediated iron-assimilation from transferrin in vitro or in a human ex vivo system.


Subject(s)
Amides/pharmacology , Iron/metabolism , Metalloproteases/pharmacology , Oxazoles/pharmacology , Transferrin/metabolism , Vibrio vulnificus/enzymology , Culture Media , DNA Primers/pharmacology , Electrophoresis, Polyacrylamide Gel , Gene Deletion , Humans , Indicators and Reagents , Liver Cirrhosis/metabolism , Mutagenesis, Insertional , Mutation/physiology , Plasmids/genetics , Reverse Transcriptase Polymerase Chain Reaction
15.
Biol Pharm Bull ; 29(4): 850-3, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16595935

ABSTRACT

We isolated a highly serine protease-producing Bacillus subtilis strain (PRY) from a clinical sample and identified it through biochemical testing and ribosomal DNA sequencing. The PRY strain exhibited a robust swarming behavior and was able to digest human transferrin efficiently, concomitantly with the production of catechol-siderophore in the exponential growth phase. The growth of PRY was in proportion to increased iron availability resulting from transferrin destruction. These results suggest that proteases of the B. subtilis PRY strain may play a significant role in the pathogenesis of human infections by facilitating siderophore-mediated iron uptake from transferrin and swarming motility.


Subject(s)
Bacillus subtilis/enzymology , Gram-Positive Bacterial Infections/microbiology , Iron/metabolism , Serine Endopeptidases/metabolism , Siderophores/pharmacology , Transferrin/metabolism , Animals , DNA, Bacterial/genetics , Milk/microbiology , Phenotype
16.
FEMS Microbiol Lett ; 257(2): 285-92, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16553865

ABSTRACT

Cyclic AMP-cAMP receptor protein (CRP) complex plays an essential role in the global regulation of Vibrio vulnificus virulence. We found that growth retardation of V. vulnificus caused by mutation of the crp gene encoding CRP was exacerbated under iron-limited conditions. Accordingly, we investigated the effect of crp mutation on the expression of the vulnibactin-mediated iron-uptake system and the ability of V. vulnificus to utilize transferrin-bound iron, and thus to grow in cirrhotic ascites, a human ex vivo system. The production of vulnibactin was suppressed, and the transcription of the vis and vuuA genes, which encode an enzyme required for vulnibactin synthesis and vulnibactin receptor protein, was also suppressed in the crp mutant. Moreover, the crp mutant could not utilize transferrin-bound iron, and its growth was severely suppressed both on transferrin-bound iron and in cirrhotic ascites. All the defects in the crp mutant were recovered by the in trans complementation of the wild-type crp gene. Putative CRP-binding sequences were found in the regulatory regions of the fur, vis and vuuA genes. These results indicate that crp mutation attenuates the ability to grow on transferrin-bound iron and in a human body fluid by down-regulating the vulnibactin-mediated iron-uptake system.


Subject(s)
Bacterial Outer Membrane Proteins/physiology , Iron/metabolism , Transferrin/metabolism , Vibrio vulnificus/metabolism , Amides/metabolism , Ascitic Fluid , Bacterial Outer Membrane Proteins/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Base Sequence , Culture Media , Down-Regulation , Humans , Molecular Sequence Data , Mutation , Oxazoles/metabolism , Receptors, Cyclic AMP/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism , Siderophores/metabolism , Vibrio vulnificus/growth & development
17.
J Microbiol Methods ; 66(3): 552-5, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16497398

ABSTRACT

The expressional levels of genes in swarmer cells can be determined by a simple method using X-gal-containing semisolid agars and lacZ-fusion transcription reporter strains of the genes concerned. However, X-gal alone inhibited the swarming of Vibrio, regardless of their ability to digest X-gal. Moreover, X-gal inhibited the growth of V. vulnificus containing functional lacZ. These effects of X-gal itself should be carefully considered when trying to determine the expression levels of genes in swarming cells using X-gal-containing semisolid agar.


Subject(s)
Chromogenic Compounds/pharmacology , Galactosides/pharmacology , Indoles/pharmacology , Vibrio/drug effects , Vibrio/physiology
18.
Biol Pharm Bull ; 29(1): 180-2, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16394536

ABSTRACT

Vibrio vulnificus hemolysin (VvhA) is inactivated in the late growth phase by its oligomerization. Albumin is known to affect the activities of many bacterial toxins. In this study, we investigated the effects of human or bovine serum albumin (HSA or BSA) on the production and activity of VvhA. HSA did not affect V. vulnificus growth and vvhA transcription. However, VvhA hemolytic activity in culture supernatants was significantly higher in the presence of HSA than in the absence of HSA. By Western blot analysis, the oligomerization of VvhA was inhibited and the remaining active VvhA monomer was increased in culture supernatants containing HSA. BSA produced similar results. These findings indicate that both HSA and BSA stabilize VvhA and delay VvhA inactivation by oligomerization, and thus enhance VvhA activity.


Subject(s)
Bacterial Proteins/pharmacology , Hemolysis/drug effects , Serum Albumin/pharmacology , Vibrio vulnificus/chemistry , Animals , Blotting, Western , Cattle , Drug Synergism , Electrophoresis, Polyacrylamide Gel , Hemolysin Proteins , Humans , In Vitro Techniques , Serum Albumin, Bovine/pharmacology , beta-Galactosidase/blood
19.
Biol Pharm Bull ; 28(7): 1294-7, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15997117

ABSTRACT

Vibrio vulnificus extracellular protease (VvpE) is believed to destroy its hemolysin (VvhA) in the late growth phase, without obvious experimental evidence. So, we attempted to elucidate the mechanism. The hemolytic activity steeply increased with the expression of the VvhA in the early growth phase, and then abruptly declined with the expression of VvpE in the late growth phase. However, the VvhA activity also abruptly declined in a VvpE-deficient mutant. In Western blot, the degradation of VvhA was not observed; instead, the oligomerization of VvhA increased with the concomitant loss of hemolytic activity. These results evidently indicate that the inactivation of VvhA is due to the novel oligomerization of VvhA by unknown mechanism, but not to the destruction of VvhA by VvpE, so that the routine functional assay measuring hemolytic activity cannot reflect the actual production of VvhA.


Subject(s)
Biopolymers , Hemolysin Proteins , Vibrio vulnificus/metabolism , Blotting, Western , Electrophoresis, Polyacrylamide Gel , Hydrolysis , Peptide Hydrolases/metabolism , Reverse Transcriptase Polymerase Chain Reaction
20.
Biol Pharm Bull ; 28(6): 1132-5, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15930764

ABSTRACT

In the present study we attempted to ascertain whether Bacillus cereus was able to produce catechol-siderophore(s), and whether it was able to utilize transferrin-bound iron. The growth of B. cereus was stimulated in proportion to the iron-saturation level of the transferrin, and catechol-siderophores were produced in inverse proportion to this level. B. cereus was proved to uptake iron from partially iron-saturated transferrin or holotransferrin, without destroying the transferrin by its proteases. The catechol-siderophores from B. cereus were able to sustain and augment its growth on the transferrin-bound iron. These results indicate that B. cereus has the ability to produce catechol-siderophores, and to utilize transferrin-bound iron as an iron source for growth, via the siderophore-mediated iron-uptake system.


Subject(s)
Bacillus cereus/metabolism , Catechols/metabolism , Iron/metabolism , Siderophores/biosynthesis , Transferrin/metabolism , Catechols/analysis , Siderophores/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...